−2.9ILS
−12.01 MILS
About KADIMASTEM
Sector
CEO
Asaf Shiloni
Headquarters
Ness Ziona
Website
Employees (FY)
12
Founded
2008
ISIN
IL0011284614
FIGI
BBG004N4ZFR6
Kadimastem Ltd. engages in developing cell therapy in the field of regenerative medicine. It develops a platform for the development and production of embryonic stem cells and various engineered pluripotent stem cells for the purpose of developing cell drugs as off-the-shelf products in the field of regenerative medicine. The company was founded by Yossi Ben Yosef and Michel Revel on October 6, 2008 and is headquartered in Ness Ziona, Israel.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of KDST is 489.4 ILA — it has increased by 0.49% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TASE exchange KADIMASTEM stocks are traded under the ticker KDST.
Yes, you can track KADIMASTEM financials in yearly and quarterly reports right on TradingView.
Like other stocks, KDST shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KADIMASTEM stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 12.00 employees. See our rating of the largest employees — is KADIMASTEM on this list?